Biopta
@biopta
Glasgow, Scotlandhttp://www.reprocell.com/efficacy-safety-adme Biotechnology ResearchOverview
About Biopta
Biopta (now REPROCELL Europe) has been providing laboratory services to the pharmaceutical industry since 2002. Our scientists specialize in human tissue research (including sourcing, handling, and experimenting) and sell a range of stem cell and 3D cell culture products as part of the wider REPROCELL group. We have recently expanded our service offering to include central laboratory and precision medicine services.
***
Our expertise covers all areas of human tissue research - including sourcing, handling, and experimenting - allowing us to act as your “Human Tissue Research Department”.
Using ethically sourced and obtained human tissues, we provide early indications of drug safety, efficacy and absorption. Our human ex vivo pharmacology models bridge the gap between animal in vivo data and the clinic.
• Human safety assays: predict adverse effects in healthy human tissues
• Human efficacy assays: use diseased human tissues to demonstrate drug efficacy
• Human absorption assays: use respiratory and gastrointestinal tissues to predict drug absorption
This invaluable human data is available during early discovery and development phases and helps reduce the number of compounds which fail in the later stages of drug development. Find out more by visiting our website.
***
Our expertise covers all areas of human tissue research - including sourcing, handling, and experimenting - allowing us to act as your “Human Tissue Research Department”.
Using ethically sourced and obtained human tissues, we provide early indications of drug safety, efficacy and absorption. Our human ex vivo pharmacology models bridge the gap between animal in vivo data and the clinic.
• Human safety assays: predict adverse effects in healthy human tissues
• Human efficacy assays: use diseased human tissues to demonstrate drug efficacy
• Human absorption assays: use respiratory and gastrointestinal tissues to predict drug absorption
This invaluable human data is available during early discovery and development phases and helps reduce the number of compounds which fail in the later stages of drug development. Find out more by visiting our website.